5 clinical trials found.
-
A Randomized Double-blind Placebo controlled Multi-center 2-part Phase 2 Study to Evaluate Efficacy Safety and Tolerability of RGH-706 in Prader-Willi Syndrome
The hypothalamus is a small but complex part of the brain. It is an important regulator of body temperature, appetite, and hormone secretion. The hypothalamus ...Phase
TRIAL ROLE: Principal Investigator
-
A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin in children with growth hormone deficiency
Purpose of the research study is to collect information to help us understand how doctors treat and manage children and adolescent with growth hormone deficiency ...Phase
TRIAL ROLE: Sub Investigator
-
NN8640-4245 - A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin in children with short stature born small for gestational age with no catch-up growth by 2 years of age or older
This research study involves children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day. Researchers will ...Phase
TRIAL ROLE: Sub Investigator
-
WUH: NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
An important part of this study is to better understand what causes type 1 diabetes, to look for new ways to identify people at risk ...Phase N/A
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A Multi-Country Non-Interventional Prospective Cohort Study Among Patients with Human Growth Hormone (hGH) Treatments Under Routine Clinical Care
This study will explore how safe and effective hGH treatments are in the long term. This study is “non-interventional” because it collects information only.Phase N/A TRIAL ROLE: Sub Investigator
